The use of cytokeratin staining in sentinel lymph node biopsy for breast cancer.

[1]  C. Compton,et al.  College of American Pathologists Conference XXXV: solid tumor prognostic factors-which, how and so what? Summary document and recommendations for implementation. Cancer Committee and Conference Participants. , 2000, Archives of pathology & laboratory medicine.

[2]  D. Page,et al.  Minimal solid tumor involvement of regional and distant sites , 1999, Cancer.

[3]  S. Edge,et al.  Effectiveness of multiple-level sectioning in detecting axillary nodal micrometastasis in breast cancer: a retrospective study with immunohistochemical analysis. , 1998, Archives of pathology & laboratory medicine.

[4]  R. J. Rosser.  Safety of sentinel lymph node dissection and significance of cytokeratin micrometastases. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  M. Fan,et al.  Lymph node micrometastases from breast carcinoma , 1997, Cancer.

[6]  Donald E. Henson,et al.  Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases , 1989 .

[7]  A. Cantor,et al.  Do Cytokeratin-Positive-Only Sentinel Lymph Nodes Warrant Complete Axillary Lymph Node Dissection in Patients with Invasive Breast Cancer? , 2000, The American surgeon.

[8]  L. Liberman,et al.  Sentinel Lymph Node Biopsy: Is It Indicated in Patients With High-Risk Ductal Carcinoma-In-Situ and Ductal Carcinoma-In-Situ With Microinvasion? , 2000, Annals of Surgical Oncology.

[9]  L. Sobin,et al.  Classification of isolated tumor cells and micrometastasis , 2000 .

[10]  K. McMasters,et al.  Defining the Optimal Surgeon Experience for Breast Cancer Sentinel Lymph Node Biopsy: A Model for Implementation of New Surgical Techniques , 2001, Annals of surgery.

[11]  M. Demeure,et al.  The clinical significance of micrometastases and molecular metastases. , 2001, Surgery.

[12]  C. Redmond,et al.  Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update , 1983, Cancer.

[13]  A. Giuliano,et al.  Intraoperative examination of the sentinel lymph node for breast carcinoma staging. , 1999, American journal of clinical pathology.

[14]  D. Page,et al.  Benign transport of breast epithelium into axillary lymph nodes after biopsy. , 2000, American journal of clinical pathology.

[15]  E. Conant,et al.  Immunohistochemistry with pancytokeratins improves the sensitivity of sentinel lymph node biopsy in patients with breast carcinoma , 1999, Cancer.

[16]  D. Reintgen,et al.  Microstaging of Breast Cancer Patients Using Cytokeratin Staining of the Sentinel Lymph Node , 1999, Annals of Surgical Oncology.